DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Halloran Consulting Group
Artificial Intelligence in Medicine: Hope or Hype?
Artificial Intelligence in Medicine: Hope or Hype?’ was originally published by Medical ...
CRO Woes: Are Companies Better Off Using In-house Resources?
This was originally published in The Pharma Letter. Click here to read the full article. ...
New Scholarship Honors Women in Life Sciences
Carolyn E. Green Scholarship established in memory of prominent industry voice will ...
Resource Optimization: Uncharted Territory in Vendor Oversight
In a recent Comprehend webinar, Laurie Halloran presented some stimulating ideas on how ...
How to get the most out of a CRO’s bid defense
How to get the most out of a CRO’s bid defense’ was originally published by The Pharma ...
Drug Development & Transactional Deals for Neurodegenerative Disorders
This poster was originally presented by Anmol Grover at GTCBio’s CNS Diseases Summit ...
How Do Top Companies Audit Their CROs?
How Do Top Companies Audit Their CROs?’ was written by Ed Miseta and originally published ...
Halloran Makes the Inc. 5000 for the Fourth Year in a Row
We are thrilled to announce that Halloran has been recognized on the Inc. 5000 list for ...
Timed Release: A Potential Inflection Point Nears for Biogen
Laurie Halloran sat down with Max Stendahl of the Boston Business Journal (BBJ) to ...
Building a Productive Relationship with the FDA: Beyond the Science
Building a Productive Relationship with the FDA’ was originally published by ...